Shigeki Namimatsu

420 total citations
17 papers, 317 citations indexed

About

Shigeki Namimatsu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shigeki Namimatsu has authored 17 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shigeki Namimatsu's work include RNA modifications and cancer (3 papers), Molecular Biology Techniques and Applications (2 papers) and Metastasis and carcinoma case studies (2 papers). Shigeki Namimatsu is often cited by papers focused on RNA modifications and cancer (3 papers), Molecular Biology Techniques and Applications (2 papers) and Metastasis and carcinoma case studies (2 papers). Shigeki Namimatsu collaborates with scholars based in Japan, Austria and Germany. Shigeki Namimatsu's co-authors include Mohammad Ghazizadeh, Yuichi Sugisaki, Zenya Naito, Ryuji Ohashi, Hiroyuki Takei, Takashi Sakatani, Akira Shimizu, Takehito Igarashi, Iwao Sugitani and Kiyoko Kawahara and has published in prestigious journals such as Journal of Histochemistry & Cytochemistry, Journal of Clinical Pathology and Human Pathology.

In The Last Decade

Shigeki Namimatsu

15 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigeki Namimatsu Japan 9 143 55 54 42 36 17 317
Petra J. Neufing Australia 12 160 1.1× 53 1.0× 48 0.9× 20 0.5× 54 1.5× 15 398
Priska Binner Germany 11 255 1.8× 29 0.5× 70 1.3× 75 1.8× 95 2.6× 15 588
Lisa McFerrin United States 8 275 1.9× 158 2.9× 69 1.3× 77 1.8× 21 0.6× 9 462
Mizuo HASHIMOTO Japan 8 196 1.4× 56 1.0× 101 1.9× 77 1.8× 19 0.5× 18 361
Aparna Draksharapu United States 5 216 1.5× 82 1.5× 47 0.9× 18 0.4× 72 2.0× 7 430
Yuko Kubo Japan 10 111 0.8× 27 0.5× 101 1.9× 81 1.9× 16 0.4× 39 367
Jose‐Ezequiel Martín Spain 13 133 0.9× 25 0.5× 27 0.5× 28 0.7× 68 1.9× 35 338
Yeon Sung Son South Korea 11 162 1.1× 40 0.7× 49 0.9× 41 1.0× 31 0.9× 16 305
Maoyong Fu China 12 161 1.1× 67 1.2× 55 1.0× 41 1.0× 37 1.0× 28 349
Yan Gu China 9 170 1.2× 61 1.1× 138 2.6× 41 1.0× 178 4.9× 18 441

Countries citing papers authored by Shigeki Namimatsu

Since Specialization
Citations

This map shows the geographic impact of Shigeki Namimatsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeki Namimatsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeki Namimatsu more than expected).

Fields of papers citing papers by Shigeki Namimatsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeki Namimatsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeki Namimatsu. The network helps show where Shigeki Namimatsu may publish in the future.

Co-authorship network of co-authors of Shigeki Namimatsu

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeki Namimatsu. A scholar is included among the top collaborators of Shigeki Namimatsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeki Namimatsu. Shigeki Namimatsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ohashi, Ryuji, Shigeki Namimatsu, Takashi Sakatani, et al.. (2018). Prognostic utility of atypical mitoses in patients with breast cancer: A comparative study with Ki67 and phosphohistone H3. Journal of Surgical Oncology. 118(3). 557–567. 17 indexed citations
2.
Ohashi, Ryuji, Shigeki Namimatsu, Keiko Yanagihara, et al.. (2017). Prognostic value of IMP3 expression as a determinant of chemosensitivity in triple-negative breast cancer. Pathology - Research and Practice. 213(9). 1160–1165. 10 indexed citations
3.
Ohashi, Ryuji, et al.. (2017). IMP3 contributes to poor prognosis of patients with metaplastic breast carcinoma: A clinicopathological study. Annals of Diagnostic Pathology. 31. 30–35. 13 indexed citations
4.
Ohashi, Ryuji, Keiko Yanagihara, Shigeki Namimatsu, et al.. (2017). Osteoclast-like giant cells in invasive breast cancer predominantly possess M2-macrophage phenotype. Pathology - Research and Practice. 214(2). 253–258. 19 indexed citations
5.
Ohashi, Ryuji, Kiyoko Kawahara, Shigeki Namimatsu, et al.. (2017). Expression of MRP1 and ABCG2 is associated with adverse clinical outcomes of papillary thyroid carcinoma with a solid component. Human Pathology. 67. 11–17. 22 indexed citations
6.
Ohashi, Ryuji, Kiyoko Kawahara, Shigeki Namimatsu, et al.. (2016). Clinicopathological significance of a solid component in papillary thyroid carcinoma. Histopathology. 70(5). 775–781. 18 indexed citations
7.
Liu, Ao, Y Sugisaki, Masaru Hosone, et al.. (2009). CD30-positive diffuse large B-cell lymphoma with microvillous features: so-called microvillous lymphoma. Journal of Clinical Pathology. 62(9). 840–844.
8.
Takizawa, Toshihiro, Hidetaka Eguchi, Shigeki Namimatsu, et al.. (2007). Histochemistry for Placenta Research: Theory and Application. Journal of Nippon Medical School. 74(4). 268–273. 4 indexed citations
9.
Namimatsu, Shigeki. (2005). Reversing the Effects of Formalin Fixation with Citraconic Anhydride and Heat: A Universal Antigen Retrieval Method. Journal of Histochemistry & Cytochemistry. 53(1). 3–11. 46 indexed citations
10.
Dai, Wei, Shigeru Sato, Kyoko Wakamatsu, et al.. (2005). A new antigen retrieval method using citraconic anhydride for immunoelectron microscopy: localization of surfactant pro-protein C (proSP-C) in the type II alveolar epithelial cells.. PubMed. 36(3-4). 219–24. 4 indexed citations
11.
Namimatsu, Shigeki, Mohammad Ghazizadeh, & Yuichi Sugisaki. (2005). Reversing the Effects of Formalin Fixation with Citraconic Anhydride and Heat: A Universal Antigen Retrieval Method. Journal of Histochemistry & Cytochemistry. 53(1). 3–11. 123 indexed citations
12.
Liu, Aimin, Yuichi Sugisaki, Masaru Hosone, & Shigeki Namimatsu. (2004). CD30+ TIA-1+ ALK+ Anaplastic Large Cell Lymphoma: Studies of Three Cases by Flow Cytometry Analysis, Immunohistochemistry and Electron Microscopy. ACTA HISTOCHEMICA ET CYTOCHEMICA. 37(1). 21–30. 1 indexed citations
13.
Sato, Shigeru, Yoshihiro Sasaki, Akiko Adachi, et al.. (2003). Use of oolong tea extract (OTE) for elastin staining and enhancement in ultrathin sections. PubMed. 36(3). 179–182. 28 indexed citations
14.
Shimizu, Kazuo, Shigeki Namimatsu, Wataru Kitagawa, et al.. (2002). Immunohistochemical, Biochemical and Immunoelectron Microscopic Analysis of Antigenic Proteins on Neuroendocrine Cell Tumors Using Monoclonal Antibody HISL-19.. Journal of Nippon Medical School. 69(4). 365–372. 3 indexed citations
15.
Namimatsu, Shigeki. (1992). Periodic acid thiosemicarbazide gelatin methenamine silver (PATSC-GMS) staining for transmission electron microscopy.. PubMed. 24(1). 19–28. 6 indexed citations
16.
Hoshi, Kenji, et al.. (1991). A case of sebaceous adeno carcinoma in the temporal region.. Skin Cancer. 6(2). 257–259. 2 indexed citations
17.
Namimatsu, Shigeki, et al.. (1989). POLYSACCHARIDE OF PERIODIC ACID THIOSEMICARBAZIDE-GELATIN METHENAMINE SILVER (PATSC-GMS) STAINING FOR ELECTRON MICROSCOPY.. ACTA HISTOCHEMICA ET CYTOCHEMICA. 22(5). 724–929. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Petra J. Neufing Breakdown of academic impact, for papers by Priska Binner Breakdown of academic impact, for papers by Lisa McFerrin Breakdown of academic impact, for papers by Mizuo HASHIMOTO Breakdown of academic impact, for papers by Aparna Draksharapu Breakdown of academic impact, for papers by Yuko Kubo Breakdown of academic impact, for papers by Jose‐Ezequiel Martín Breakdown of academic impact, for papers by Yeon Sung Son Breakdown of academic impact, for papers by Maoyong Fu Breakdown of academic impact, for papers by Yan Gu
Rankless by CCL
2026